The cancer biomarker panel status was associated with neither microsatellite instability (MSI) status nor BRAF mutation status, although all cancers negative for the biomarker panel (n = 4) were MSS and had no BRAF V600E hotspot mutation. Here, BRAF is linked to cancer.